Cargando…

Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya

Sub-Saharan Africa carries the biggest burden of the human immunodeficiency virus type 1 (HIV-1)/AIDS epidemic and is in an urgent need of an effective vaccine. CD8(+) T cells are an important component of the host immune response to HIV-1 and may need to be harnessed if a vaccine is to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Yehia S., Borthwick, Nicola J., Moyo, Nathifa, Murakoshi, Hayato, Akahoshi, Tomohiro, Siliquini, Francesca, Hannoun, Zara, Crook, Alison, Hayes, Peter, Fast, Patricia E., Mutua, Gaudensia, Jaoko, Walter, Silva-Arrieta, Sandra, Llano, Anuska, Brander, Christian, Takiguchi, Masafumi, Hanke, Tomáš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349992/ https://www.ncbi.nlm.nih.gov/pubmed/32485938 http://dx.doi.org/10.3390/vaccines8020260

Ejemplares similares

Novel, in-natural-infection subdominant HIV-1 CD8(+) T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines
por: Borthwick, Nicola, et al.
Publicado: (2017)

Novel Nested Peptide Epitopes Recognized by CD4(+) T Cells Induced by HIV-1 Conserved-Region Vaccines
por: Borthwick, Nicola, et al.
Publicado: (2020)

Identification of novel HIV-1-derived HLA-E-binding peptides
por: Hannoun, Zara, et al.
Publicado: (2018)

Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines
por: Wee, Edmund G., et al.
Publicado: (2021)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens
por: Moyo, Nathifa, et al.
Publicado: (2017)

CD8(+) T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
por: Murakoshi, Hayato, et al.
Publicado: (2018)

Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens
por: Zou, Chengcheng, et al.
Publicado: (2019)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine
por: Rahim, Md Niaz, et al.
Publicado: (2019)

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
por: Wee, Edmund G., et al.
Publicado: (2019)

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
por: Wee, Edmund G., et al.
Publicado: (2022)

Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1
por: Zhang, Yu, et al.
Publicado: (2020)

Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach
por: Chikata, Takayuki, et al.
Publicado: (2019)

Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
por: Murakoshi, Hayato, et al.
Publicado: (2018)

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
por: Mutua, Gaudensia, et al.
Publicado: (2016)

Virological, Immune and Host genetics Markers in the Control of HIV Infection
por: Mothe, Beatriz, et al.
Publicado: (2009)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
por: Mutua, Gaudensia, et al.
Publicado: (2019)

Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes
por: Kuse, Nozomi, et al.
Publicado: (2021)

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1
por: Borthwick, Nicola J., et al.
Publicado: (2018)

Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2022)

Ethnicity and Delay in Measles Vaccination in a Nairobi Slum
por: Ettarh, Remare R., et al.
Publicado: (2012)

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics
por: Akahoshi, Tomohiro, et al.
Publicado: (2020)

Critical effect of Pol escape mutations associated with detrimental allele HLA-C(∗)15:05 on clinical outcome in HIV-1 subtype A/E infection
por: Murakoshi, Hayato, et al.
Publicado: (2021)

Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8(+) T Cells and Accumulation of HLA-Associated Escape Mutations
por: Zhang, Yu, et al.
Publicado: (2021)

Childbearing desires and behaviour: a prospective assessment in Nairobi slums
por: Machiyama, Kazuyo, et al.
Publicado: (2019)

Adenovirus DNA Polymerase Loses Fidelity on a Stretch of Eleven Homocytidines during Pre-GMP Vaccine Preparation
por: Hannoun, Zara, et al.
Publicado: (2022)

Intimate partner violence among HIV-positive women in Nairobi, Kenya
por: Brooks, RD, et al.
Publicado: (2019)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020)

Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele
por: Zhang, Yu, et al.
Publicado: (2022)

STING Ligand-Mediated Priming of Functional CD8(+) T Cells Specific for HIV-1-Protective Epitopes from Naive T Cells
por: Kuse, Nozomi, et al.
Publicado: (2021)

The impact of HLA-Cw*12:02 on control of HIV-1 infection
por: Koyanagi, M, et al.
Publicado: (2012)

Multidrug-Resistant Bacterial Isolates Recovered from Herbal Medicinal Products Sold in Nairobi, Kenya
por: Korir, Richard, et al.
Publicado: (2017)

Childhood vaccination in informal urban settlements in Nairobi, Kenya: Who gets vaccinated?
por: Mutua, Martin K, et al.
Publicado: (2011)

Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
por: Olvera, Alex, et al.
Publicado: (2021)

Intimate Partner Violence, Human Rights Violations, and HIV among Women in Nairobi, Kenya
por: Andrews, Courtney, et al.
Publicado: (2020)

PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi
por: Njuguna, Irene N., et al.
Publicado: (2014)

Contraceptive Adoption, Discontinuation, and Switching among Postpartum Women in Nairobi's Urban Slums
por: Mumah, Joyce N., et al.
Publicado: (2015)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Determinants of immunization inequality among urban poor children: evidence from Nairobi’s informal settlements
por: Egondi, Thaddaeus, et al.
Publicado: (2015)

Community perception of abortion, women who abort and abortifacients in Kisumu and Nairobi counties, Kenya
por: Ushie, Boniface Ayanbekongshie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_spgadd26c5vbhrs7s0434evfku